¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 1) : 2022-03-30

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 1) : 2022-03-30
±³À°ÀÏÀÚ : 2022-03-30
±³À°Àå¼Ò : (¿Â, ¿ÀÇÁ¶óÀÎ º´Çà) ¿ÀÇÁ¶óÀÎ Àå¼Ò: ¼­¿ï ÄÚ¿¢½º  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) APASL 2022 (DAY 1)
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : APASL 2022 Áغñ»ç¹«±¹
¿¬¶ôó : 02-707-0091  
À̸ÞÀÏ : apasl2022@insession.co.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 15 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 800,000¿ø      
ºñ°í Category Early Bird Rate Regular Rate Onsite Rate December 31(Fri), 2021 February 20(Sun), 2022 Off-line Virtual Off-line Virtual Off-line VirtualAPASL Member USD 300 USD200 USD400 USD300 USD 500 USD 400Non APASL Member USD 500 USD 300 USD 600 USD 400 USD 700 USD 500Trainee/Resident/Nurse USD 200 USD 100 USD 300 USD 200 USD 400 USD 300Accompanying Person USD 150 - USD 200 - USD 300 -Industry Partner USD 600 USD 600 USD 700 USD 700 USD 800 USD 800 / *»çÀüµî·Ï2022³â 2¿ù 20ÀÏ(ÀÏ)±îÁö [ÇöÀå] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 15¸¸¿ø, µ¿¹ÝÀÚ 15¸¸¿ø, Industry Partner 70¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 25¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 12¸¸¿ø, Industry Partner 70¸¸¿ø, *ÇöÀåµî·Ï [ÇöÀå] Àü¹®ÀÇ 35¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 18¸¸¿ø, µ¿¹ÝÀÚ 18¸¸¿ø, Industry Partner 80¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ/Àü°øÀÇ/°£È£»ç 15¸¸¿ø, Industry Partner 80¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-30 101, 1F 10:30~10:50 Introduction to single-cell RNA sequencing (including nuclear RNA-sequecing)  Jong-Eun Park(Korea Advanced Institute of Science and Technology) 
±³À°½Ã°£ 03-30 101, 1F 10:50~11:20 Study of the human liver cell atlas  Thomas Baumert(INSERM, University of Strasbourg) 
±³À°½Ã°£ 03-30 101, 1F 11:20~11:50 Single-cell RNA sequencing in HCC  Zemin Zhang(School of Life Sciences, Peking University) 
Åä·Ð 03-30 101, 1F 11:50~12:00 Discussion  () 
±³À°½Ã°£ 03-30 101, 1F 13:30~13:50 Overview of the liver immune system  Eui-Cheol Shin(Korea Advanced Institute of Science and Technology) 
±³À°½Ã°£ 03-30 101, 1F 13:50~14:10 Characteristics of liver NK cells  Cliona O(School of Medicine, Trinity Biomedical Science Institute, Trinity College Dublin) 
±³À°½Ã°£ 03-30 101, 1F 14:10~14:30 T cell responses against HBV  Masanori Isogawa(Research Center for Drug and Vaccine Development, NIID) 
±³À°½Ã°£ 03-30 101, 1F 14:30~14:50 T-cell engineering for the treatment of liver diseases  Antonio Bertoletti(Duke-NUS Medical School) 
Åä·Ð 03-30 101, 1F 14:50~15:00 Discussion  () 
±³À°½Ã°£ 03-30 101, 1F 15:30~15:50 Update in HBV research  Peter Revill(Royal Melbourne Hospital) 
±³À°½Ã°£ 03-30 101, 1F 15:50~16:10 Recent progress in HBV entry  Koichi Watashi(National Institute of Infectious Diseases) 
±³À°½Ã°£ 03-30 101, 1F 16:10~16:30 Development of capsid inhibitors  Sung-Gyoo Park(College of Pharmacy Seoul National University) 
±³À°½Ã°£ 03-30 101, 1F 16:30~16:50 HBV integration and HCC  Shiou-Hwei Yeh(National Taiwan University Hospital) 
Åä·Ð 03-30 101, 1F 16:50~17:00 Discussion  () 
±³À°½Ã°£ 03-30 102, 1F 10:30~10:50 Emerging role of artificial intelligence and big data in liver diseases  Wai-Kay Seto(The University of Hong Kong) 
±³À°½Ã°£ 03-30 102, 1F 10:50~11:10 Clinical research with big data in hepatology: promises and challenges  Terry Cheuk-Fung Yip(Faculty of Medicine, The Chinese University of Hong Kong) 
±³À°½Ã°£ 03-30 102, 1F 11:10~11:30 Deep learning using electronic medical records in liver diseases  Tung-Hung Su(National Taiwan University Hospital) 
±³À°½Ã°£ 03-30 102, 1F 11:30~11:50 Machine-learning approach for novel predictive models  Ryosuke Tateishi(Graduate School of Medicine, The University of Tokyo) 
Åä·Ð 03-30 102, 1F 11:50~12:00 Discussion  () 
±³À°½Ã°£ 03-30 102, 1F 13:30~13:50 Human genome and liver diseases  Masashi Mizokami(National Center for Global Health and Medicine) 
±³À°½Ã°£ 03-30 102, 1F 13:50~14:10 Genetic and genomic methods to study risk of HBV and HCV infection and patient outcome  Hwai-I Yang(Genomic Research Center, Academia Sinica) 
±³À°½Ã°£ 03-30 102, 1F 14:10~14:30 Continuous molecular spectrum of liver cancers associated with radio-genomic and histologic features  Hyun Goo Woo(Ajou University School of Medicine) 
±³À°½Ã°£ 03-30 102, 1F 14:30~14:50 How to translate genomic understandings into clinical practice  Jean-Charles Nault(Jean Verdier Hospital) 
Åä·Ð 03-30 102, 1F 14:50~15:00 Discussion  () 
±³À°½Ã°£ 03-30 102, 1F 15:30~15:50 How to write a good paper?  Seung Up Kim(Yonsei University College of Medicine) 
±³À°½Ã°£ 03-30 102, 1F 15:50~16:10 Tips for selecting right journal for submission  Jia-Horng Kao(National Taiwan University College of Medicine) 
±³À°½Ã°£ 03-30 102, 1F 16:10~16:30 Tips for impressing the editor  Jean-Charles Nault(Jean Verdier Hospital) 
±³À°½Ã°£ 03-30 102, 1F 16:30~16:50 Reasons why some papers are accepted or rejected?  Paolo Angeli(University-Teaching Hospital of Padova) 
Åä·Ð 03-30 102, 1F 16:50~17:00 Discussion  () 
±³À°½Ã°£ 03-30 201+202+203, 2F 09:00~09:20 APASL 2022 PG course: Future trends in hepatology  Jeong Won Jang(College of Medicine, The Catholic University of Korea) 
±³À°½Ã°£ 03-30 201+202+203, 2F 09:20~09:40 Personalized treatment of viral hepatitis  Teerha Piratvisuth(Songklanagarind Hospital, Prince of Songkla University) 
±³À°½Ã°£ 03-30 201+202+203, 2F 09:40~10:00 Genetics and epigenetics in non-alcoholic fatty liver disease  Won Kim(Seoul National University College of Medicine) 
±³À°½Ã°£ 03-30 201+202+203, 2F 10:00~10:20 Translating omics data into biomarker discovery for liver cancer  Irene O. L. Ng(The University of Hong Kong) 
Åä·Ð 03-30 201+202+203, 2F 10:20~10:30 Discussion  () 
±³À°½Ã°£ 03-30 201+202+203, 2F 10:30~10:50 NAFLD versus lean NAFLD or MAFLD  Vincent Wong(Faculty of Medicine, The Chinese University of Hong Kong) 
±³À°½Ã°£ 03-30 201+202+203, 2F 10:50~11:10 Targeting the gut-liver-brain connection  Jasmohan S. Bajaj(Virginia Commonwealth University School of Medicine) 
±³À°½Ã°£ 03-30 201+202+203, 2F 11:10~11:30 Innovative strategies for a cure of hepatitis B  Seng Gee Lim(National University Health System) 
±³À°½Ã°£ 03-30 201+202+203, 2F 11:30~11:50 Immuno-oncology in liver cancer: A change of paradigm  Maria Reig(Hospital Clinic, University of Barcelona) 
Åä·Ð 03-30 201+202+203, 2F 11:50~12:00 Discussion  () 
±³À°½Ã°£ 03-30 201+202+203, 2F 13:30~13:50 New therapeutic targets in AIH, PBC, and PSC  Atsushi Tanaka(Teikyo University School of Medicine) 
±³À°½Ã°£ 03-30 201+202+203, 2F 13:50~14:10 Intestinal immune-microbiome interactions in alcoholic hepatitis  Ki Tae Suk(Hallym University College of Medicine) 
±³À°½Ã°£ 03-30 201+202+203, 2F 14:10~14:30 Immuno-microenvironment in NASH-associated HCC  Amany Zekry(St George Hospital) 
±³À°½Ã°£ 03-30 201+202+203, 2F 14:30~14:50 Immune tolerance and rejection in liver transplantation  Jong Young Choi(College of Medicine, The Catholic University of Korea) 
Åä·Ð 03-30 201+202+203, 2F 14:50~15:00 Discussion  () 
±³À°½Ã°£ 03-30 201+202+203, 2F 15:30~15:50 Coagulopathy in cirrhosis: Balancing between bleeding and thrombotic state  Ashok Choudhury(Institute of Liver and Biliary Sciences) 
±³À°½Ã°£ 03-30 201+202+203, 2F 15:50~16:10 Pulmonary complications of cirrhosis  Diana A Payawal(Fatima University Medical Center) 
±³À°½Ã°£ 03-30 201+202+203, 2F 16:10~16:30 Beta adrenergic blockade in cirrhosis: Do good or harm?  Dao Viet Hang(Hanoi Medical University) 
±³À°½Ã°£ 03-30 201+202+203, 2F 16:30~16:50 Managing acute-on-chronic liver failure to successful recovery or transplant  Rajiv Jalan(University College London Medical School, Royal Free Hospital) 
Åä·Ð 03-30 201+202+203, 2F 16:50~17:00 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 1) : 2022-03-30""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 2) : 2022-03-31
´ÙÀ½±Û 2022³â ´ëÇÑÀÓ»óÅëÇÕÀÇÇÐȸ Çмú´ëȸ : 2022-03-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20222 °æ±â ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ ¿ëÀÎÁö¿ª Çмú´ëȸ : 2024-04-28 0 15 2024-03-26
20221 ¼­¿ï (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ : 2024-04-28 0 16 2024-03-26
20220 ¼­¿ï 2024³â ´ëÇÑÇ׳ëÈ­ÇÐȸ Á¦23ȸ Ãá°èÇмú´ëȸ : 2024-04-28 0 11 2024-03-26
20219 Àü³² 2024³â Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãá°èÇмú´ëȸ : 2024-04-27 0 6 2024-03-26
20218 °­¿ø 2024³â ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ °­¿øÁöȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-04-27 0 7 2024-03-26
20217 °æ±â 2024³â ´ëÇѽºÆ÷Ã÷°úÇС¤¿îµ¿ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-27 0 6 2024-03-26
20216 ¼­¿ï ´ëÇÑÁßȯÀÚÀÇÇÐȸ (¿Â¶óÀÎ) The 18th Basic Critical Care Review Course (BCCRC) : 2024-04-27 0 9 2024-03-26
20215 °æ±â ´ëÇѵΰæºÎ¿Ü°úÇÐȸ 2024 Ãá°è µÎ°æºÎ ÇÕµ¿¿¬¼öȸ : 2024-04-27 0 8 2024-03-26
20214 ¼­¿ï ´ëÇÑÁßȯÀÚÀÇÇÐȸ The 44th KSCCM Annual Congress ¡¤ Acute and Critical Care Conference 2024(2ÀÏÂ÷) : 2024-04-26 0 5 2024-03-26
20213 °æ±â °í·Á´ëÇб³¾È»êº´¿ø ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(¸¸¼ººñºÎºñµ¿¿°) : 2024-04-26 0 3 2024-03-26
20212 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ(Biomechanics in Glaucoma) : 2024-04-26 0 3 2024-03-26
20211 ºÎ»ê ´ëÇѾȰúÇÐȸ ºÎ»êÁöȸ Á¦ 509ȸ ÇмúÁý´ãȸ : 2024-04-25 0 6 2024-03-26
20210 ¼­¿ï ´ëÇÑÁßȯÀÚÀÇÇÐȸ The 44th KSCCM Annual Congress ¡¤ Acute and Critical Care Conference 2024(1ÀÏÂ÷) : 2024-04-25 0 7 2024-03-26
20209 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ÀÇ ¿¹¹æÁ¢Á¾ Àü·«°ú ³ëÇÏ¿ì: HPV ¹é½ÅÀ» Áß½ÉÀ¸·Î : 2024-04-25 0 9 2024-03-26
20208 ±¤ÁÖ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Neuropsychiatry/û³âÁ¤½Å°Ç°­ : 2024-04-25 0 4 2024-03-26
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷